Gene-Disorder Association · Article
Gene
CXCR4C-X-C Motif Chemokine Receptor 4
×
First reported
2002
Supporting publications
15
Manually curatedApproved treatment annotated
Association Review
In brief
The association between CXCR4 (C-X-C Motif Chemokine Receptor 4) and Ovarian Cancer is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
8
Compounds
1
Trials
97of 3,298 via CXCR4 compounds
Publications
15
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Ovarian Cancer
The disorder
19 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features
3 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
Interventions
Therapeutics
1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
3,298 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
15 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
16 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access